These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15977489)

  • 1. Assessment of the side effects of antipsychotic medication.
    Walker H; MacAulay K
    Nurs Stand; 2005 Jun 15-21; 19(40):41-6. PubMed ID: 15977489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice.
    Morrison P; Gaskill D; Meehan T; Lunney P; Lawrence G; Collings P
    Aust N Z J Ment Health Nurs; 2000 Dec; 9(4):166-76. PubMed ID: 11887267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement.
    Lambert TJ; Cock N; Alcock SJ; Kelly DL; Conley RR
    Hum Psychopharmacol; 2003 Jul; 18(5):405-11. PubMed ID: 12858330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians.
    Hodge K; Jespersen S
    Int J Ment Health Nurs; 2008 Feb; 17(1):2-8. PubMed ID: 18211398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for neuroleptic side-effects.
    Marland G; McSherry W
    Nurs Times; 1998 Mar 25-31; 94(12):54-5. PubMed ID: 9616644
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring adverse drug reactions: scales, profiles, and checklists.
    Jordan S; Knight J; Pointon D
    Int Nurs Rev; 2004 Dec; 51(4):208-21. PubMed ID: 15530161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
    Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
    Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing patients with antipsychotic drug-induced hyperprolactinaemia.
    Jones A; Jones M
    Nurs Stand; 2008 Oct 15-21; 23(6):48-55; quiz 56. PubMed ID: 18988568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reported allergies to antipsychotic agents in a long-term psychiatric hospital.
    Nurenberg JR; Schleifer SJ
    J Psychiatr Pract; 2009 Nov; 15(6):489-92. PubMed ID: 19934726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability.
    Teeluckdharry S; Sharma S; O'Rourke E; Tharian P; Gondalekar A; Nainar F; Roy M
    J Intellect Disabil; 2013 Sep; 17(3):223-35. PubMed ID: 23801356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported side effects in children and adolescents taking risperidone.
    Byrne S; Walter G; Hunt G; Soh N; Cleary M; Duffy P; Crawford G; Krabman P; Concannon P; Malhi G
    Australas Psychiatry; 2010 Feb; 18(1):42-5. PubMed ID: 20136533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.